Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1(23)
  2. 10(9)
  3. 10C12(4)
  4. 10F.9G2(23)
  5. 116-13.1(10)
  6. 11B11(20)
  7. 12G5(5)
  8. 14-4-4S(10)
  9. 145-2C11(19)
  10. 15(9)
  11. 15-3-1S(4)
  12. 15A7(4)
  13. 16-10A1(19)
  14. 178 (LALAPG)(5)
  15. 17A2(8)
  16. 18B12(7)
  17. 1a3(5)
  18. 1A8(19)
  19. 1D11.1(5)
  20. 1D11.16.8(10)
  21. 1D3(14)
  22. 1F6(9)
  23. 1G9(26)
  24. 1H1(6)
  25. 2(23)
  26. 2.4G2(19)
  27. 20D5(14)
  28. 20H2(5)
  29. 225(4)
  30. 22D1(19)
  31. 24(5)
  32. 29E.2A3(16)
  33. 29F.1A12(19)
  34. 2D5(10)
  35. 2D5-1.9(9)
  36. 2H7(19)
  37. 3(28)
  38. 30-H12(19)
  39. 33D1(40)
  40. 37(9)
  41. 38(5)
  42. 38/42(4)
  43. 384-35(5)
  44. 3E8#(4)
  45. 3G8(15)
  46. 3H10.1(19)
  47. 3H3(19)
  48. 4(5)
  49. 43(9)
  50. 480(14)
  51. 4A9(18)
  52. 4E1.2(9)
  53. 4LO3311(18)
  54. 50-6(5)
  55. 500A2(20)
  56. 509F6(8)
  57. 51(9)
  58. 53-5.8(19)
  59. 53-6.7(19)
  60. 55R-170(15)
  61. 55R-593(15)
  62. 5C8(3)
  63. 5G11(11)
  64. 6B11(5)
  65. 7B10(15)
  66. 7E.17G9(19)
  67. 7G7B6(19)
  68. 8C8(9)
  69. 9(5)
  70. 9000000000(10)
  71. 927(18)
  72. 9a2(9)
  73. 9D9(19)
  74. 9E9(8)
  75. 9H10(23)
  76. A4C8.1-Do9(10)
  77. A7R34(6)
  78. Abituzumab(3)
  79. Abrilumab(3)
  80. Aducanumab(3)
  81. AF6-88.5(9)
  82. Afasevikumab(3)
  83. AFS98(19)
  84. ALF-161(10)
  85. Amatuximab(3)
  86. Anifrolumab(3)
  87. Anrukinzumab(3)
  88. Apamistamab(3)
  89. Aprutumab(3)
  90. Atezolizumab(3)
  91. Atibuclimab(3)
  92. Avelumab(3)
  93. Avizakimab(3)
  94. B122(10)
  95. B22/249(14)
  96. B6H12(21)
  97. B7/21(5)
  98. B8-24-3(14)
  99. B8.2C12(5)
  100. Bamlanivimab(3)
  101. Bapineuzumab(3)
  102. Basiliximab(3)
  103. Batoclimab(3)
  104. Bavbio(5)
  105. Bavituximab(3)
  106. BC8(19)
  107. BE29G1(15)
  108. Begelomab(3)
  109. Belantamab(3)
  110. Belimumab(3)
  111. Bemarituzumab(3)
  112. Bermekimab(3)
  113. Bersanlimab(3)
  114. Bertilimumab(3)
  115. Bevacizumab(3)
  116. Bexmarilimab(3)
  117. Bimekizumab(3)
  118. Bivatuzumab(3)
  119. Bleselumab(3)
  120. Blosozumab(3)
  121. Bococizumab(3)
  122. Brazikumab(3)
  123. Brentuximab(3)
  124. Briakinumab(3)
  125. Brodalumab(3)
  126. Burosumab(3)
  127. BVD6-24G2(4)
  128. C1.18.4(11)
  129. C17.8(7)
  130. C71/16(16)
  131. C9B7W(18)
  132. Cadbio(5)
  133. Camidanlumab(3)
  134. Camrelizumab(3)
  135. Canakinumab(3)
  136. Caplacizumab(7)
  137. Carlumab(3)
  138. CD28.2(7)
  139. Cedelizumab(3)
  140. Cemiplimab(3)
  141. Cendakimab(3)
  142. Cetuximab(3)
  143. CHK-166(10)
  144. CHK152(5)
  145. Cibbio(5)
  146. Cixutumumab(3)
  147. Clazakizumab(3)
  148. Clenoliximab(3)
  149. Clervonafusp Alfa(4)
  150. Clesrovimab(3)
  151. Codrituzumab(3)
  152. Coltuximab(3)
  153. Cusatuzumab(3)
  154. CXCR3-173(18)
  155. Cy34.1(22)
  156. D12(4)
  157. D5(10)
  158. Dacetuzumab(3)
  159. Daclizumab(3)
  160. Daratumumab(3)
  161. DATK32(15)
  162. Daxdilimab(3)
  163. DC101(14)
  164. Dectrekumab(3)
  165. Denintuzumab(3)
  166. Denosumab(3)
  167. DREG56(5)
  168. Dupilumab(3)
  169. Durvalumab(3)
  170. Dusigitumab(3)
  171. E18(10)
  172. Edrecolomab(3)
  173. Efalizumab(3)
  174. EGFR.1(14)
  175. Eldelumab(3)
  176. Elipovimab(3)
  177. Elotuzumab(3)
  178. Emapalumab(3)
  179. Emibetuzumab(3)
  180. Enfortumab(3)
  181. Enibarcimab(3)
  182. Enoblituzumab(3)
  183. Enokizumab(3)
  184. Epratuzumab(5)
  185. Eptinezumab(3)
  186. Erenumab(3)
  187. ERIC-1(11)
  188. Erlizumab(3)
  189. Etaracizumab(3)
  190. Etokimab(3)
  191. Etrolizumab(3)
  192. Evinacumab(3)
  193. Evolocumab(3)
  194. Faralimomab(3)
  195. Farletuzumab(3)
  196. Fasinumab(3)
  197. FD441.8(15)
  198. Felzartamab(3)
  199. Fezakinumab(3)
  200. FGK4.5(19)
  201. FIB21(9)
  202. FIB27(3)
  203. FIB504(24)
  204. Ficlatuzumab(3)
  205. Figitumumab(3)
  206. Fletikumab(3)
  207. Fontolizumab(3)
  208. Foralumab(3)
  209. FR70(11)
  210. Fremanezumab(3)
  211. Fresolimumab(3)
  212. Frunevetmab(3)
  213. Fulranumab(3)
  214. G11(5)
  215. G28.5(19)
  216. G8.8(14)
  217. Galcanezumab(3)
  218. Gantenerumab(3)
  219. Gatralimab(3)
  220. Gemtuzumab(3)
  221. Gevokizumab(3)
  222. Giloralimab(3)
  223. Gimsilumab(3)
  224. GIR 208(9)
  225. Girentuximab(3)
  226. GK1.5(19)
  227. GL1(14)
  228. GL113(3)
  229. Glembatumumab(3)
  230. Grebio(5)
  231. Guselkumab(3)
  232. H22(20)
  233. H57-597(14)
  234. HB-14(7)
  235. HDB-4A7(9)
  236. HEK/1/85a/7a(18)
  237. HK1.4(10)
  238. HK2.1(15)
  239. HK5.3(15)
  240. HKSP(10)
  241. HKSP84(10)
  242. HM48-1(17)
  243. I21/7(15)
  244. I3/2.3(10)
  245. Ibalizumab(3)
  246. ICRF44(5)
  247. Ieramilimab(3)
  248. Ifibio(5)
  249. Ifinatamab(3)
  250. IK22/5(9)
  251. IM7(19)
  252. Indusatumab(3)
  253. Infliximab(3)
  254. Inolimomab(3)
  255. Intetumumab(3)
  256. Ipilimumab(3)
  257. Iratumumab(3)
  258. Isatuximab(3)
  259. Iscalimab(3)
  260. Itepekimab(3)
  261. Itolizumab(3)
  262. Ivuxolimab(3)
  263. Ixekizumab(3)
  264. J43(4)
  265. JAMA-147(10)
  266. JES5-2A5(4)
  267. JES6-1A12(5)
  268. JES6-5H4(4)
  269. Keliximab(3)
  270. L243(10)
  271. Lacnotuzumab(3)
  272. Lebrikizumab(3)
  273. Lemzoparlimab(3)
  274. Lenzilumab(3)
  275. Lerdelimumab(3)
  276. Lintuzumab(3)
  277. LO-CD2a(4)
  278. Lucatumumab(3)
  279. Lulizumab(3)
  280. Lumiliximab(3)
  281. Lusvertikimab(3)
  282. M1/69(8)
  283. M1/70(15)
  284. M290(4)
  285. M5/114.15.2(18)
  286. M5/49.4.1(10)
  287. Magrolimab(3)
  288. MAR 18.5(18)
  289. MAR1-5A3(19)
  290. Margetuximab(3)
  291. Matuzumab(3)
  292. Mavrilimumab(3)
  293. MB22-11(14)
  294. MD5-1(15)
  295. MECA-367(14)
  296. MECA-89(10)
  297. MEL-14(15)
  298. Metelimumab(3)
  299. Mezagitamab(3)
  300. MFL3(18)
  301. MIB-5E9.1(5)
  302. MIG-2F5-5(18)
  303. Minretumomab(3)
  304. Mirikizumab(3)
  305. Mirvetuximab(3)
  306. Mitazalimab(3)
  307. MJ18(18)
  308. MJ7/18(8)
  309. Monalizumab(3)
  310. Motavizumab(3)
  311. MP1-22E9(19)
  312. MP4-25D2(7)
  313. MP5-20F3(4)
  314. MPC-11(10)
  315. MR1(4)
  316. Mupadolimab(3)
  317. Muromonab(3)
  318. N418(5)
  319. Nadunolimab(3)
  320. Namilumab(3)
  321. Naratuximab(3)
  322. Natalizumab(3)
  323. Naxitamab(3)
  324. Necitumumab(3)
  325. Nemolizumab(3)
  326. Nerelimomab(3)
  327. Nesvacumab(3)
  328. Netakimab(3)
  329. Nipocalimab(3)
  330. Nivolumab(3)
  331. Obexelimab(3)
  332. Ocaratuzumab(3)
  333. Odulimomab(3)
  334. Ofatumumab(3)
  335. OKT-4(19)
  336. OKT10(19)
  337. Oleclumab(3)
  338. Olokizumab(3)
  339. Omalizumab(3)
  340. Omburtamab(3)
  341. Onvatilimab(3)
  342. Otelixizumab(3)
  343. Otilimab(3)
  344. OX-26(18)
  345. OX-7(18)
  346. OX-86(19)
  347. OX-90(18)
  348. Ozanezumab(3)
  349. Ozuriftamab(3)
  350. P84(9)
  351. Palivizumab(3)
  352. Pamrevlumab(3)
  353. Panitumumab(3)
  354. Parsatuzumab(3)
  355. Pascolizumab(3)
  356. Patbio(5)
  357. Pateclizumab(3)
  358. Patritumab(3)
  359. PC61(14)
  360. Pembrolizumab(3)
  361. Penpulimab(3)
  362. Perakizumab(3)
  363. Pertuzumab(3)
  364. Pinatuzumab(3)
  365. Pivekimab(3)
  366. PK136(19)
  367. Polatuzumab(3)
  368. Ponezumab(3)
  369. Ponsegromab(3)
  370. PS/2(18)
  371. Quetmolimab(3)
  372. R1-2(3)
  373. R4-6A2(12)
  374. RA3-6B2(19)
  375. Ramucirumab(3)
  376. Ravagalimab(3)
  377. RB6-8C5(19)
  378. Relatlimab(3)
  379. RG9-1(18)
  380. Rilotumumab(3)
  381. Ripertamab(3)
  382. Rituximab(5)
  383. RM134L(14)
  384. RM27-3E5(23)
  385. RMP1-14(26)
  386. RMP1-14-mAbMods(5)
  387. RMP1-14-mAbMods (D265A)(5)
  388. RMP1-14-mAbMods (LALA-PG)(5)
  389. RMP1-30(6)
  390. RMT1-10(14)
  391. RMT3-23(10)
  392. RMT4-53(10)
  393. Robatumumab(3)
  394. Rolinsatamab(3)
  395. Romosozumab(3)
  396. Rontalizumab(3)
  397. Rosopatamab(3)
  398. Rovalpituzumab(3)
  399. Rozanolixizumab(3)
  400. Sabatolimab(3)
  401. Sacituzumab(3)
  402. Sarilumab(3)
  403. Satralizumab(3)
  404. Secukinumab(3)
  405. Selicrelumab(3)
  406. Sifalimumab(3)
  407. Siltuximab(3)
  408. Simtuzumab(3)
  409. Sintilimab(3)
  410. Siplizumab(3)
  411. Sirukumab(3)
  412. SJ25-C1(6)
  413. Sofituzumab(3)
  414. Sotigalimab(3)
  415. Spesolimab(3)
  416. Sutimlimab(3)
  417. Suvizumab(3)
  418. T24/31(19)
  419. T29/33(5)
  420. T3-3A1(5)
  421. T56/14(5)
  422. TA-99(10)
  423. Tabalumab(3)
  424. Tadocizumab(3)
  425. Tafasitamab(3)
  426. Talbio(5)
  427. TAN1-7(19)
  428. Tanezumab(3)
  429. Tecbio(5)
  430. Teneliximab(3)
  431. Teplizumab(3)
  432. Teprotumumab(3)
  433. Tezepelumab(3)
  434. TIF-3C5(9)
  435. Tilavonemab(3)
  436. Tilvestamab(3)
  437. Tinurilimab(3)
  438. Tiragolumab(3)
  439. Tislelizumab(3)
  440. TKS-1(18)
  441. TN3-19.12(19)
  442. Tocilizumab(3)
  443. Toripalimab(3)
  444. Tositumomab(3)
  445. Tovetumab(3)
  446. TR75-54.7(15)
  447. Tralokinumab(3)
  448. Trastuzumab(3)
  449. Tregalizumab(3)
  450. TRFK5(14)
  451. Tusamitamab(3)
  452. TY/23(25)
  453. TY25(9)
  454. Ublituximab(3)
  455. UC10-4F10-11(19)
  456. UC3-10A6(15)
  457. UC7-13D5(10)
  458. UCHL-1(5)
  459. UCHM-1(5)
  460. UCHT-1(10)
  461. UCHT-2(5)
  462. UCHT-4(5)
  463. Uliledlimab(3)
  464. Upifitamab(3)
  465. Urabrelimab(3)
  466. Urelumab(3)
  467. Ustekinumab(3)
  468. Utomilumab(3)
  469. Vadastuximab(3)
  470. Vanalimab(3)
  471. Varisacumab(3)
  472. Varlilumab(3)
  473. Vatelizumab(3)
  474. Vedolizumab(3)
  475. Veltuzumab(3)
  476. Vibostolimab(3)
  477. Visilizumab(3)
  478. VL-4(10)
  479. Volociximab(3)
  480. Vunakizumab(3)
  481. W6/32(15)
  482. Xentuzumab(3)
  483. XMG1.2(19)
  484. Y-3(15)
  485. Y-3P(10)
  486. YN1/1.7.4(19)
  487. YTS-169(19)
  488. YTS191(18)
  489. Zagotenemab(3)
  490. Zalutumumab(3)
  491. Zanolimumab(3)
  492. Zilovertamab(3)
  493. Ziltivekimab(3)
  494. Zinlirvimab(3)
  495. Zolbetuximab(3)
  496. Zolimomab(3)
  497. ZV67(5)
Applications
Isotype
Hersteller

In Vivo Antibodies

13369 Artikel

pro Seite

Seite:
  1. 118
  2. 119
  3. 120
  4. 121
  5. 122
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Tabalumab Biosimilar -­ Biotin Research Grade Produkt-Datenblatt downloaden Biosimilars Other ICH5103B-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Tabalumab Biosimilar -­ Dylight488 Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FC, IHC CHO cells ICH5103D488-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Tabalumab Biosimilar -­ HRP Research Grade Produkt-Datenblatt downloaden Biosimilars Other ICH5103HRP-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Sarilumab Biosimilar -­ Biotin Research Grade Produkt-Datenblatt downloaden Biosimilars Other ICH5107B-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Sarilumab Biosimilar -­ Dylight488 Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FC, IHC CHO cells ICH5107D488-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Sarilumab Biosimilar -­ HRP Research Grade Produkt-Datenblatt downloaden Biosimilars Other ICH5107HRP-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Lebrikizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5058UL-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Lebrikizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5058UL-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Lebrikizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5058UL-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Lebrikizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5058UL-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Lebrikizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5058UL-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Lebrikizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5058UL-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Dupilumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5062UL-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Dupilumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5062UL-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Dupilumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5062UL-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Dupilumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5062UL-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Dupilumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5062UL-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Dupilumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5062UL-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Clazakizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5063UL-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Clazakizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5063UL-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Clazakizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5063UL-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Clazakizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5063UL-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Clazakizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5063UL-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Clazakizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5063UL-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Enfortumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5070UL-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Name Preis
Tabalumab Biosimilar -­ Biotin Research Grade Anmelden Tabalumab Biosimilar - Biotin Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Tabalumab Biosimilar -­ Dylight488 Research Grade Anmelden Tabalumab Biosimilar - Dylight488 Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FC, IHC
Host CHO cells
ArtNr.
Menge 100 ug
Lieferbar
Tabalumab Biosimilar -­ HRP Research Grade Anmelden Tabalumab Biosimilar - HRP Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Sarilumab Biosimilar -­ Biotin Research Grade Anmelden Sarilumab Biosimilar - Biotin Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Sarilumab Biosimilar -­ Dylight488 Research Grade Anmelden Sarilumab Biosimilar - Dylight488 Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FC, IHC
Host CHO cells
ArtNr.
Menge 100 ug
Lieferbar
Sarilumab Biosimilar -­ HRP Research Grade Anmelden Sarilumab Biosimilar - HRP Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Lebrikizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Lebrikizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar
Lebrikizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Lebrikizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 10 mg
Lieferbar
Lebrikizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Lebrikizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 1 mg
Lieferbar
Lebrikizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Lebrikizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 20 mg
Lieferbar
Lebrikizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Lebrikizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 50 mg
Lieferbar
Lebrikizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Lebrikizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 5 mg
Lieferbar
Dupilumab Biosimilar -­ Ultra Low Endotoxin Anmelden Dupilumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar
Dupilumab Biosimilar -­ Ultra Low Endotoxin Anmelden Dupilumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 10 mg
Lieferbar
Dupilumab Biosimilar -­ Ultra Low Endotoxin Anmelden Dupilumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 1 mg
Lieferbar
Dupilumab Biosimilar -­ Ultra Low Endotoxin Anmelden Dupilumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 20 mg
Lieferbar
Dupilumab Biosimilar -­ Ultra Low Endotoxin Anmelden Dupilumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 50 mg
Lieferbar
Dupilumab Biosimilar -­ Ultra Low Endotoxin Anmelden Dupilumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 5 mg
Lieferbar
Clazakizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Clazakizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar
Clazakizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Clazakizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 10 mg
Lieferbar
Clazakizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Clazakizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 1 mg
Lieferbar
Clazakizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Clazakizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 20 mg
Lieferbar
Clazakizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Clazakizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 50 mg
Lieferbar
Clazakizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Clazakizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 5 mg
Lieferbar
Enfortumab Biosimilar -­ Ultra Low Endotoxin Anmelden Enfortumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar

13369 Artikel

pro Seite

Seite:
  1. 118
  2. 119
  3. 120
  4. 121
  5. 122
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top